GMX1778
SIGMA/SML0646 - ≥98% (HPLC)
Synonym: CHS 828; CHS-828; GMX 1778; N-
CAS Number: 200484-11-3
Empirical Formula (Hill Notation): C19H22ClN5O
Molecular Weight: 371.86
Linear Formula: C19H22ClN5O
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C19H22ClN5O/c20-16-5-7 |
| InChI key | BOIPLTNGIAPDBY-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | Clc1ccc(cc1)OCCCCCCNC(=N |
| solubility | DMSO: 20 mg/mL, clear |
| storage temp. | −20°C |
| Application: | GMX1778 has been used as NAMPT inhibitor, to study its effects on nicotinamide adenine dinucleotide (NAD) contents of SH-SY5Y cells exposed to Vacor. |
| Biochem/physiol Actions: | GMX1778 (CHS-828) is a competitive inhibitor of nicotinamide phosphoribosyltransferase (NAMPT) that exhibits a potent anticancer activity both in vitro and in vivo. GMX1778 exerts a cytotoxic effect by decreasing the cellular level of NAD+. GMX1778 increases intracellular ROS in cancer cells but does not induce ROS in normal cells. |
| Biochem/physiol Actions: | GMX1778 can regulate redox status and has the ability to simulate ROS in cancer cells. |
| Biochem/physiol Actions: | GMX1778 is a competitive inhibitor of nicotinamide phosphoribosyltransferase (NAMPT). |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 - H315 - H319 - H335 |
| Precautionary statements | P301 + P312 + P330 - P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | T |
| Risk Statements | 25-36/37/38 |
| Safety Statements | 26-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |


